Evidence map›Paper›PMID 31696404›Full record

ArticleJournal of cardiovascular translational research2020

Atrial Fibrillation Is Associated with Recurrent Ventricular Arrhythmias After LVAD Implant: Incidence and Impact in a Consecutive Series.

Kathleen T Hickey, Paolo C Colombo, Yoshifumi Naka, Arthur R Garan, Melana Yuzefpolskaya, Hasan Garan, Elaine Y Wan, Robert R Sciacca, Isaac Goldenthal, Angelo B Biviano

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiovascular translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. PRRX1 Loss-of-Function Mutations Underlying Familial Atrial Fibrillation.Journal of the American Heart Association · 2021
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kathleen T HickeyColumbia University School of Nursing, 622 W. 168th St, New York, NY, 10032, USA.
Paolo C ColomboColumbia University Irving Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA.
Yoshifumi NakaColumbia University Irving Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA.
Arthur R GaranColumbia University Irving Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA.
Melana YuzefpolskayaColumbia University Irving Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA.
Hasan GaranColumbia University Irving Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA.
Elaine Y WanColumbia University Irving Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA.
Robert R SciaccaColumbia University School of Nursing, 622 W. 168th St, New York, NY, 10032, USA.
Isaac GoldenthalColumbia University Irving Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA.
Angelo B BivianoColumbia University Irving Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA. ab542@cumc.columbia.edu.
Columbia University Irving Medical Center · USColumbia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined left-ventricular assist device (LVAD) patients with pre-LVAD ventricular arrhythmias (VAs) to determine the rate of recurrent post-LVAD VAs and the impact of pre-LVAD atrial fibrillation (AF) on recurrent post-LVAD VAs. Medical records of 195 consecutive LVAD patients were reviewed. Descriptive statistics were generated and Cox proportional hazard models were used to assess the association of clinical variables with the time to recurrent VA. Forty-seven percent of 195 CHF patients who received LVAD-manifested significant VAs prior to LVAD implant (82% Heartmate II, 14% HVAD, 4% other; median follow-up = 17 months), 41% of whom manifested recurrent post-LVAD VAs. Pre-LVAD AF was associated with recurrent VAs (hazard ratio = 3.73; 95% CI 1.33, 10.48; p = 0.012). Recurrent VAs were associated with increased mortality (hazard ratio = 3.06; 95% CI 1.17, 7.98; p = 0.023). A history of AF is prevalent in over half of LVAD patients with recurrent VAs and is associated with time to recurrence of VA.

Indexed as

Heart-Assist DevicesVentricular Function, LeftAgedAtrial FibrillationFemaleHeart FailureHeart RateHumansIncidenceMaleMiddle AgedNew York CityProsthesis ImplantationRecurrenceRetrospective StudiesRisk AssessmentAtrial fibrillationCardiac outcomesLeft ventricular assist devicesVentricular arrhythmias

Identifiers

PMID31696404
OpenAlexW2984326971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.